Literature DB >> 23166294

The MYC-associated protein CDCA7 is phosphorylated by AKT to regulate MYC-dependent apoptosis and transformation.

R Montgomery Gill1, Timothy V Gabor, Amber L Couzens, Michael P Scheid.   

Abstract

Cell division control protein A7 (CDCA7) is a recently identified target of MYC-dependent transcriptional regulation. We have discovered that CDCA7 associates with MYC and that this association is modulated in a phosphorylation-dependent manner. The prosurvival kinase AKT phosphorylates CDCA7 at threonine 163, promoting binding to 14-3-3, dissociation from MYC, and sequestration to the cytoplasm. Upon serum withdrawal, induction of CDCA7 expression in the presence of MYC sensitized cells to apoptosis, whereas CDCA7 knockdown reduced MYC-dependent apoptosis. The transformation of fibroblasts by MYC was reduced by coexpression of CDCA7, while the non-MYC-interacting protein Δ(156-187)-CDCA7 largely inhibited MYC-induced transformation. These studies provide insight into a new mechanism by which AKT signaling to CDCA7 could alter MYC-dependent growth and transformation, contributing to tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23166294      PMCID: PMC3554214          DOI: 10.1128/MCB.00276-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  62 in total

1.  Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display.

Authors:  B Wang; H Yang; Y C Liu; T Jelinek; L Zhang; E Ruoslahti; H Fu
Journal:  Biochemistry       Date:  1999-09-21       Impact factor: 3.162

2.  The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins.

Authors:  L Rao; M Debbas; P Sabbatini; D Hockenbery; S Korsmeyer; E White
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

3.  Induction of apoptosis in fibroblasts by c-myc protein.

Authors:  G I Evan; A H Wyllie; C S Gilbert; T D Littlewood; H Land; M Brooks; C M Waters; L Z Penn; D C Hancock
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

Review 4.  The Oscar-worthy role of Myc in apoptosis.

Authors:  Natalie Meyer; Sam S Kim; Linda Z Penn
Journal:  Semin Cancer Biol       Date:  2006-07-14       Impact factor: 15.707

5.  ATM promotes apoptosis and suppresses tumorigenesis in response to Myc.

Authors:  Raju V Pusapati; Robert J Rounbehler; SungKi Hong; John T Powers; Mingshan Yan; Kaoru Kiguchi; Mark J McArthur; Paul K Wong; David G Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 6.  Reflecting on 25 years with MYC.

Authors:  Natalie Meyer; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2008-12       Impact factor: 60.716

7.  The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.

Authors:  J Li; L Simpson; M Takahashi; C Miliaresis; M P Myers; N Tonks; R Parsons
Journal:  Cancer Res       Date:  1998-12-15       Impact factor: 12.701

8.  The Myc target gene JPO1/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivo.

Authors:  Rebecca C Osthus; Baktiar Karim; Julia E Prescott; B Douglas Smith; Michael McDevitt; David L Huso; Chi V Dang
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

9.  Regulation of neuronal survival by the serine-threonine protein kinase Akt.

Authors:  H Dudek; S R Datta; T F Franke; M J Birnbaum; R Yao; G M Cooper; R A Segal; D R Kaplan; M E Greenberg
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

10.  The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells.

Authors:  Qing-Bai She; David B Solit; Qing Ye; Kathryn E O'Reilly; Jose Lobo; Neal Rosen
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

View more
  26 in total

1.  AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay.

Authors:  Xiulei Mo; Qi Qi; Andrei A Ivanov; Qiankun Niu; Yin Luo; Jonathan Havel; Russell Goetze; Sydney Bell; Carlos S Moreno; Lee A D Cooper; Margaret A Johns; Fadlo R Khuri; Yuhong Du; Haian Fu
Journal:  Mol Pharmacol       Date:  2017-01-13       Impact factor: 4.436

2.  Characterising cis-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues.

Authors:  Mingfeng Zhang; Soren Lykke-Andersen; Bin Zhu; Wenming Xiao; Jason W Hoskins; Xijun Zhang; Lauren M Rost; Irene Collins; Martijn van de Bunt; Jinping Jia; Hemang Parikh; Tongwu Zhang; Lei Song; Ashley Jermusyk; Charles C Chung; Bin Zhu; Weiyin Zhou; Gail L Matters; Robert C Kurtz; Meredith Yeager; Torben Heick Jensen; Kevin M Brown; Halit Ongen; William R Bamlet; Bradley A Murray; Mark I McCarthy; Stephen J Chanock; Nilanjan Chatterjee; Brian M Wolpin; Jill P Smith; Sara H Olson; Gloria M Petersen; Jianxin Shi; Laufey Amundadottir
Journal:  Gut       Date:  2017-06-20       Impact factor: 23.059

3.  Cellular heterogeneity in the ureteric progenitor niche and distinct profiles of branching morphogenesis in organ development.

Authors:  Elisabeth A Rutledge; Jean-Denis Benazet; Andrew P McMahon
Journal:  Development       Date:  2017-07-13       Impact factor: 6.868

4.  SPOCK1 is upregulated in recurrent glioblastoma and contributes to metastasis and Temozolomide resistance.

Authors:  Fengbo Yu; Guihong Li; Junxia Gao; Yuxue Sun; Pengfei Liu; Haijun Gao; Peiwen Li; Ting Lei; Yong Chen; Ye Cheng; Xiao Zhai; Arash J Sayari; Haiyan Huang; Qingchun Mu
Journal:  Cell Prolif       Date:  2016-02-28       Impact factor: 6.831

Review 5.  MYC cofactors: molecular switches controlling diverse biological outcomes.

Authors:  Stephen R Hann
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-17       Impact factor: 6.915

6.  Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.

Authors:  Camille Laurent; Alina Nicolae; Cécile Laurent; Fabien Le Bras; Corinne Haioun; Virginie Fataccioli; Nadia Amara; José Adélaïde; Arnaud Guille; Jean-Marc Schiano; Bruno Tesson; Alexandra Traverse-Glehen; Marie-Pierre Chenard; Lénaïg Mescam; Anne Moreau; Catherine Chassagne-Clement; Joan Somja; Frédéric Escudié; Marc André; Nadine Martin; Laetitia Lacroix; François Lemonnier; Anne-Sophie Hamy; Fabien Reyal; Marie Bannier; Lucie Oberic; Nais Prade; François-Xavier Frénois; Asma Beldi-Ferchiou; Marie-Helene Delfau-Larue; Reda Bouabdallah; Daniel Birnbaum; Pierre Brousset; Luc Xerri; Philippe Gaulard
Journal:  Blood       Date:  2020-01-30       Impact factor: 22.113

7.  The molecular basis of breast cancer pathological phenotypes.

Authors:  Yujing J Heng; Susan C Lester; Gary Mk Tse; Rachel E Factor; Kimberly H Allison; Laura C Collins; Yunn-Yi Chen; Kristin C Jensen; Nicole B Johnson; Jong Cheol Jeong; Rahi Punjabi; Sandra J Shin; Kamaljeet Singh; Gregor Krings; David A Eberhard; Puay Hoon Tan; Konstanty Korski; Frederic M Waldman; David A Gutman; Melinda Sanders; Jorge S Reis-Filho; Sydney R Flanagan; Deena Ma Gendoo; Gregory M Chen; Benjamin Haibe-Kains; Giovanni Ciriello; Katherine A Hoadley; Charles M Perou; Andrew H Beck
Journal:  J Pathol       Date:  2016-12-29       Impact factor: 7.996

8.  Downregulation of ZBTB24 hampers the G0/1- to S-phase cell-cycle transition via upregulating the expression of IRF-4 in human B cells.

Authors:  J Liang; R Yan; G Chen; J Feng; W-W Wu; W Ren; C Zhu; Y Zhao; X-M Gao; J Wang
Journal:  Genes Immun       Date:  2016-04-21       Impact factor: 2.676

9.  LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.

Authors:  Jun Gao; Chao Dai; Xin Yu; Xiang-Bao Yin; Fan Zhou
Journal:  Cell Cycle       Date:  2020-03-16       Impact factor: 4.534

10.  DDX6 Orchestrates Mammalian Progenitor Function through the mRNA Degradation and Translation Pathways.

Authors:  Ying Wang; Marc Arribas-Layton; Yifang Chen; Jens Lykke-Andersen; George L Sen
Journal:  Mol Cell       Date:  2015-09-24       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.